Victor J. Lotti

Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists

B. Evans, Kenneth E. Rittle, Mark G. Bock et al. · Journal of Medicinal Chemistry · 1988 · 1.4K citations · Full text

Peptide Hormone Cholecystokinin, Medicinal Chemistry, Drug Target +15

Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist.

Robert S. Chang, Victor J. Lotti · Proceedings of the National Academy of Sciences · 1986 · 542 citations · Full text

Molecular Pharmacology, Cck Receptors, Pharmacological Characterization +14

A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260

Victor J. Lotti, Raymond S.L. Chang · European Journal of Pharmacology · 1989 · 398 citations · Full text

Neuropeptides, Brain Cholecystokinin Receptor, Functional Selectivity +10

Two distinct angiotensin II receptor binding sites in rat adrenal revealed by new selective nonpeptide ligands.

Robert S. Chang, Victor J. Lotti · Molecular Pharmacology · 1990 · 181 citations

TEMPERATURE RESPONSES TO MONOAMINES AND AN INHIBITOR OF MAO INJECTED INTO THE CEREBRAL VENTRICLES OF RATS

W. Feldberg, Victor J. Lotti · British Journal of Pharmacology and Chemotherapy · 1967 · 163 citations · Full text